NCT02798029View on ClinicalTrials.gov

Frameless Fractionated Stereotactic Radiation in Treating Patients With Brain Metastases

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

August 8, 2016

Primary Completion Date

April 19, 2024

Study Completion Date

April 19, 2024

Conditions
Metastatic Malignant Neoplasm in the Brain
Interventions
RADIATION

Frameless Fractionated Stereotactic Radiation Therapy

Trial Locations (4)

77030

M D Anderson Cancer Center, Houston

77079

MD Anderson West Houston, Houston

77384

MD Anderson in The Woodlands, Conroe

87106

Presbyterian Hospital, Albuquerque

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT02798029 - Frameless Fractionated Stereotactic Radiation in Treating Patients With Brain Metastases | Biotech Hunter | Biotech Hunter